PT - JOURNAL ARTICLE AU - Trujillo, Monica AU - Cheung, Kristen AU - Gao, Anna AU - Hoxie, Irene AU - Kannoly, Sherin AU - Kubota, Nanami AU - San, Kaung Myat AU - Smyth, Davida S. AU - Dennehy, John J. TI - Protocol for Safe, Affordable, and Reproducible Isolation and Quantitation of SARS-CoV-2 RNA from Wastewater AID - 10.1101/2021.02.16.21251787 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.16.21251787 4099 - http://medrxiv.org/content/early/2021/02/17/2021.02.16.21251787.short 4100 - http://medrxiv.org/content/early/2021/02/17/2021.02.16.21251787.full AB - The following protocol describes our workflow for processing wastewater with the goal of detecting the genetic signal of SARS-CoV-2. The steps include pasteurization, virus concentration, RNA extraction, and quantification by RT-qPCR. We include auxiliary steps that provide new users with tools and strategies that will help troubleshoot key steps in the process. This protocol is one of the safest, cheapest, and most reproducible approaches for the detection of SARS-CoV-2 RNA in wastewater. Furthermore, the RNA obtained using this protocol, minus the pasteurization step, can be sequenced both using a targeted approach sequencing specific regions or the whole genome. The protocol was adopted by the New York City Department of Environmental Protection in August 2020 to support their efforts in monitoring SARS-CoV-2 prevalence in wastewater in all five boroughs of the city. Owing to a pasteurization step, it is safe for use in a BSL1+ facility. This step also increases the genetic signal of the virus while making the protocol safe for the personnel involved. This protocol could be used to isolate a variety of other clinically relevant viruses from wastewater and serve as a foundation of a wastewater surveillance strategy for monitoring community spread of known and emerging viral pathogens.Competing Interest StatementWe were awarded a next-generation sequencing sponsorship from Qiagen Inc. that included materials and supplies used in isolating RNA. This sponsorship did not influence the results and conclusions reported in this paper.Funding StatementFunding for this project was provided by the New York City Department of Environmental Protection. Qiagen Inc. provided materials and supplies as part of an NGS sponsorship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Queens College Institutional Biosafety Committee approval Protocol IBC-03.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data associated with this manuscript are available on https://datadryad.org/: https://doi.org/10.5061/dryad.zkh189396. https://www.protocols.io/view/protocol-brr6m59e/ https://doi.org/10.5061/dryad.zkh189396